ಸೆಪ್ಟೆಂ . 25, 2024 20:16 Back to list

40372-66-5

The compound with the identifier 40372-66-5 is known as Clopidogrel, an important medication primarily used as an antiplatelet agent. Clopidogrel is widely prescribed to reduce the risk of heart attacks, strokes, and other cardiovascular events in patients with established cardiovascular diseases or those at high risk.

The compound with the identifier 40372-66-5 is known as Clopidogrel, an important medication primarily used as an antiplatelet agent. Clopidogrel is widely prescribed to reduce the risk of heart attacks, strokes, and other cardiovascular events in patients with established cardiovascular diseases or those at high risk.

This compound is especially important for patients who have undergone procedures like angioplasty or have implanted stents. In such cases, there is a heightened risk of thrombosis, making antiplatelet therapy essential. Clopidogrel is often used in conjunction with aspirin, another antiplatelet medication, to provide a dual approach to preventing thrombotic events, particularly in individuals with acute coronary syndrome.

40372-66-5

One of the unique features of Clopidogrel is its prodrug status. Upon administration, Clopidogrel requires metabolic activation to convert it into its active form. This conversion occurs primarily in the liver through the cytochrome P450 enzyme system. As a result, the efficacy of Clopidogrel can be influenced by genetic variations in these enzymes. Some individuals may be classified as poor metabolizers, leading to reduced therapy effectiveness and, consequently, a higher risk of cardiovascular events. This has led to an increased focus on pharmacogenomics in managing patients who are prescribed Clopidogrel.

Clopidogrel is generally well-tolerated, although it can lead to gastrointestinal issues, such as bleeding and ulcers, particularly in those taking it alongside other non-steroidal anti-inflammatory drugs (NSAIDs). As with any medication, monitoring and managing potential side effects is essential in clinical practice.

In the realm of modern medicine, Clopidogrel has proven to be a revolutionary drug that significantly impacts the management of cardiovascular disease. As research continues, healthcare professionals are exploring ways to enhance its application, optimize patient outcomes, and minimize adverse effects. The importance of personalized medicine and understanding individual responses to Clopidogrel will undoubtedly pave the way for improved therapeutic strategies in the future. By integrating genetic testing and more comprehensive patient assessments, doctors can make informed decisions that enhance both the safety and efficacy of cardiovascular treatments.

cas number 63449 41 2